Patent details

EP2295035 Title: Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor

Basic Information

Publication number:
EP2295035
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP101735066
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor
French Title of Invention:
Compositions pharmaceutiques à double action s'appuyantes aux superstructures des inhibiteurs des recepterus des antagonistes d'angiotension (arb) avec des inhibiteurs neutres de l'endopeptidase (nep)
German Title of Invention:
Pharmazeutische Zusammensetzungen mit Kombinierter Aktivität Basierend auf Superstrukturen von Angiotensin Rezeptor Antagonisten/Blockern (arb) mit Neutralen Endopeptidase (nep) Inhibitoren
SPC Number:

Dates

Filing date:
04/11/2008
Grant date:
18/05/2016
EP Publication Date:
18/05/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/03/2011
EP B1 Publication Date:
18/05/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/11/2028
Renunciation date:
Revocation date:
06/08/2017
Annulment date:

Owner

From:
04/11/2008
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
Royce Alan Edward
Address:
United States (US)

2

Name:
Zannou Erika Aina
Address:
United States (US)

3

Name:
Ruegger Colleen
Address:
United States (US)

4

Name:
Hu Jiahui
Address:
United States (US)

5

Name:
Al-Fayoumi Suliman
Address:
United States (US)

6

Name:
Kumaraperumal Natrajan
Address:
United States (US)

Priority

Priority Number:
985668 P
Priority Date:
06/11/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/00;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201712
Publication date:
22/03/2017
Description:
Opposition procedure started

2

Issue number:
201750
Publication date:
13/12/2017
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/10/2016
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages